首页> 外国专利> Using an oral pharmacological synthesis method, which includes at least one selected steroid antagonist versus antagonist versus antagonist versus antagonist versus antagonist versus antagonist versus antagonist versus antagonist

Using an oral pharmacological synthesis method, which includes at least one selected steroid antagonist versus antagonist versus antagonist versus antagonist versus antagonist versus antagonist versus antagonist versus antagonist

机译:使用口服药理合成方法,其包括至少一种选择的类固醇拮抗剂对拮抗剂对拮抗剂对拮抗剂对拮抗剂对拮抗剂对拮抗剂对拮抗剂对拮抗剂对拮抗剂

摘要

Pharmaceutical composition comprising at least one opioid antagonist or its Salt, such as naloxone, naltrexone or nalbufino, Additionally you can at least understand of pharmaceutically ACTIVE AGENT.As oxicona, morphine or other; and its use for the treatment of urinary retention.
机译:包含至少一种阿片类拮抗剂或其盐的药物组合物,例如纳洛酮,纳曲酮或纳布非诺,此外,您至少可以了解药学上的活性剂。及其用于尿retention留的治疗。

著录项

  • 公开/公告号CL2011000044A1

    专利类型

  • 公开/公告日2011-06-17

    原文格式PDF

  • 申请/专利权人 EURO-CELTIQUE S.A.;

    申请/专利号CL20110000044

  • 发明设计人 HOPP. MICHAEL LEYENDECKER PETRA.;

    申请日2011-01-07

  • 分类号A61K31/485;A61P13/02;

  • 国家 CL

  • 入库时间 2022-08-21 18:06:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号